Area of research
Hematology · Genetics
Research interest
Research interests include Hemophilia Treatment and Research, Platelet Disorders and Treatments, Blood Coagulation and Thrombosis Mechanisms, and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO).
Considerations for shared decision management in previously untreated patients with hemophilia A or B.
International consensus recommendations on the management of people with haemophilia B
International consensus recommendations on the management of people with haemophilia B.
Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHC.
Delivery of AAV-based gene therapy through haemophilia centres-A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC.
Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.
Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey.
The factor VIII treatment history of non-severe hemophilia A-Response from original authors Abdi et al.
Commentary on "Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach" - Will we ever be able to avoid inhibitor formation in hemophilia A?
Re-personalization and stratification of hemophilia care in an evolving treatment landscape.
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations
A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders
Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
The incidence and magnitude of fibrinolytic activation in trauma patients